The LGBTQ+ dating app has agreed to buy the parent company of Freddie, an HIV-prevention care provider. Grindr will pay US$190 million in cash and US$60 million in the company’s common stock. Grindr may also pay up to US$70 million more if PurposeMed meets certain performance milestones next year. (The Logic)
Talking point: PurposeMed has raised about US$20 million to date, according to PitchBook, including US$12 million in growth financing in March 2025 with backing from True North Fund, Panache Ventures and BDC. The deal is Grindr’s first major acquisition since launching in 2009. It’s part of the company’s efforts to broaden its business beyond dating and into health and wellness for the LGBTQ+ community. Grindr CEO George Arison said the company aims to reduce new HIV infections by using its reach to connect more gay men with Freddie’s medical services, helping them access and stay on the HIV-prevention medication PrEP. The arrangement will help connect Grindr users with testing and prescriptions through Freddie’s partner clinics and arrange medication delivery through the app.
Loading...
You have shared 5 articles this month and reached the maximum amount of shares available.
CloseIf you would like to purchase a sharing license please contact The Logic support at [email protected].
CloseYou have gifted 0 article(s) this month and have 5 remaining.
Recipients will be able to read the full text of the article after submitting their email address. They will not have access to other articles or subscriber benefits.
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.